233 related articles for article (PubMed ID: 29435774)
1. PET Molecular Targets and Near-Infrared Fluorescence Imaging of Atherosclerosis.
Celeng C; de Keizer B; Merkely B; de Jong P; Leiner T; Takx RAP
Curr Cardiol Rep; 2018 Feb; 20(2):11. PubMed ID: 29435774
[TBL] [Abstract][Full Text] [Related]
2. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.
Verjans JW; Osborn EA; Ughi GJ; Calfon Press MA; Hamidi E; Antoniadis AP; Papafaklis MI; Conrad MF; Libby P; Stone PH; Cambria RP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1087-1095. PubMed ID: 27544892
[TBL] [Abstract][Full Text] [Related]
3. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
[TBL] [Abstract][Full Text] [Related]
4. Fully integrated high-speed intravascular optical coherence tomography/near-infrared fluorescence structural/molecular imaging in vivo using a clinically available near-infrared fluorescence-emitting indocyanine green to detect inflamed lipid-rich atheromata in coronary-sized vessels.
Lee S; Lee MW; Cho HS; Song JW; Nam HS; Oh DJ; Park K; Oh WY; Yoo H; Kim JW
Circ Cardiovasc Interv; 2014 Aug; 7(4):560-9. PubMed ID: 25074255
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural-molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery.
Kim S; Lee MW; Kim TS; Song JW; Nam HS; Cho HS; Jang SJ; Ryu J; Oh DJ; Gweon DG; Park SH; Park K; Oh WY; Yoo H; Kim JW
Eur Heart J; 2016 Oct; 37(37):2833-2844. PubMed ID: 26787442
[TBL] [Abstract][Full Text] [Related]
6. Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging.
Ughi GJ; Verjans J; Fard AM; Wang H; Osborn E; Hara T; Mauskapf A; Jaffer FA; Tearney GJ
Int J Cardiovasc Imaging; 2015 Feb; 31(2):259-68. PubMed ID: 25341407
[TBL] [Abstract][Full Text] [Related]
7. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
8. Detection of Atherosclerotic Inflammation by
Tarkin JM; Joshi FR; Evans NR; Chowdhury MM; Figg NL; Shah AV; Starks LT; Martin-Garrido A; Manavaki R; Yu E; Kuc RE; Grassi L; Kreuzhuber R; Kostadima MA; Frontini M; Kirkpatrick PJ; Coughlin PA; Gopalan D; Fryer TD; Buscombe JR; Groves AM; Ouwehand WH; Bennett MR; Warburton EA; Davenport AP; Rudd JH
J Am Coll Cardiol; 2017 Apr; 69(14):1774-1791. PubMed ID: 28385306
[TBL] [Abstract][Full Text] [Related]
9. Macrophage targeted theranostic strategy for accurate detection and rapid stabilization of the inflamed high-risk plaque.
Song JW; Nam HS; Ahn JW; Park HS; Kang DO; Kim HJ; Kim YH; Han J; Choi JY; Lee SY; Kim S; Oh WY; Yoo H; Park K; Kim JW
Theranostics; 2021; 11(18):8874-8893. PubMed ID: 34522216
[No Abstract] [Full Text] [Related]
10. Atherosclerosis imaging using PET: Insights and applications.
Sriranjan RS; Tarkin JM; Evans NR; Le EPV; Chowdhury MM; Rudd JHF
Br J Pharmacol; 2021 Jun; 178(11):2186-2203. PubMed ID: 31517992
[TBL] [Abstract][Full Text] [Related]
11. F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.
Kang WJ
Korean J Radiol; 2015; 16(6):1257-61. PubMed ID: 26576114
[TBL] [Abstract][Full Text] [Related]
12. Intravascular Molecular Imaging: Near-Infrared Fluorescence as a New Frontier.
Khraishah H; Jaffer FA
Front Cardiovasc Med; 2020; 7():587100. PubMed ID: 33330648
[TBL] [Abstract][Full Text] [Related]
13. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury.
Jaffer FA; Calfon MA; Rosenthal A; Mallas G; Razansky RN; Mauskapf A; Weissleder R; Libby P; Ntziachristos V
J Am Coll Cardiol; 2011 Jun; 57(25):2516-26. PubMed ID: 21679853
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
[TBL] [Abstract][Full Text] [Related]
15. Reviewing imaging modalities for the assessment of plaque erosion.
Collet C; Conte E; Mushtaq S; Brouwers S; Shinke T; Coskun AU; Pu Z; Hakim D; Stone PH; Andreini D
Atherosclerosis; 2021 Feb; 318():52-59. PubMed ID: 33129585
[TBL] [Abstract][Full Text] [Related]
16. Quantitative intravascular biological fluorescence-ultrasound imaging of coronary and peripheral arteries in vivo.
Bozhko D; Osborn EA; Rosenthal A; Verjans JW; Hara T; Kellnberger S; Wissmeyer G; Ovsepian SV; McCarthy JR; Mauskapf A; Stein AF; Jaffer FA; Ntziachristos V
Eur Heart J Cardiovasc Imaging; 2017 Nov; 18(11):1253-1261. PubMed ID: 28031233
[TBL] [Abstract][Full Text] [Related]
17. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
[TBL] [Abstract][Full Text] [Related]
18. Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.
Senders ML; Hernot S; Carlucci G; van de Voort JC; Fay F; Calcagno C; Tang J; Alaarg A; Zhao Y; Ishino S; Palmisano A; Boeykens G; Meerwaldt AE; Sanchez-Gaytan BL; Baxter S; Zendman L; Lobatto ME; Karakatsanis NA; Robson PM; Broisat A; Raes G; Lewis JS; Tsimikas S; Reiner T; Fayad ZA; Devoogdt N; Mulder WJM; Pérez-Medina C
JACC Cardiovasc Imaging; 2019 Oct; 12(10):2015-2026. PubMed ID: 30343086
[TBL] [Abstract][Full Text] [Related]
19.
Creager MD; Hohl T; Hutcheson JD; Moss AJ; Schlotter F; Blaser MC; Park MA; Lee LH; Singh SA; Alcaide-Corral CJ; Tavares AAS; Newby DE; Kijewski MF; Aikawa M; Di Carli M; Dweck MR; Aikawa E
Circ Cardiovasc Imaging; 2019 Jan; 12(1):e007835. PubMed ID: 30642216
[TBL] [Abstract][Full Text] [Related]
20. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
